Latest News
News from the FDA/CDC
FDA approves first pill for postpartum depression
Zuranolone is a neuroactive steroid that acts on GABAA receptors in the brain responsible for regulating mood, arousal, behavior, and cognition....
From the Journals
Bipolar disorder tied to a sixfold increased risk of early death
The current study included individuals from various sources including inpatient and outpatient registries as well as social insurance registries...
Latest News
Long COVID disability court battles just ‘tip of iceberg’
When it comes to long COVID, completing disability paperwork is increasingly becoming part of standard care for providers.
Latest News
Depression at any stage of life tied to increased dementia risk
The double risk persists regardless of when in life depression is diagnosed.
Latest News
Medicare to pay for at-home dementia care coordination
The program is voluntary and will be open to Medicare-enrolled clinicians and other providers who can assemble an interdisciplinary care team and...
From the Journals
Oxycodone tied to persistent use only after vaginal delivery
Oxycodone receipt was not associated with persistent opioid use, compared with codeine.
Latest News
Could your practice be more profitable if you outsource?
Some practices have used outsourcing to solve problems like high staff turnover, tight budgets, and inefficient use of staff.
From the Journals
Reassuring data on stimulants for ADHD in kids and later substance abuse
Experts hope the study findings will quell the stigma surrounding stimulant use by children with ADHD.
From the Journals
Psilocybin shows early promise for anorexia nervosa
The researchers cautioned that the effects on eating disorder psychopathology were “highly variable.”
From the Journals
Fast-acting postpartum depression drug is effective
Approximately 17% of women are affected by postpartum depression during pregnancy or after birth.
Latest News
Hospital guards snoop through patient records, cost hospital $240K
“I think the problem is absolutely growing.”